Uptake of best medical therapy: Secondary prevention of cardiovascular disease in vascular surgical patients in Western Australia
Document Type
Journal Article
Publication Title
Angiology
Volume
75
Issue
3
First Page
288
Last Page
294
PubMed ID
36927174
Publisher
Sage
School
School of Medical and Health Sciences
RAS ID
56580
Abstract
Best medical therapy (BMT) for peripheral arterial disease (PAD), carotid artery stenosis (CAS) and abdominal aortic aneurysm (AAA) involving concomitant use of antiplatelets, lipid-lowering agents, and blood pressure control, improves patient survival and prevents clinical cardiovascular disease (CVD). We performed a single-center cross-sectional study, over a 4-year period, describing BMT use in Western Australian patients with symptomatic PAD, CAS and AAA in the community. Overall, 45.3% of our cohort (n = 1689) were on appropriate BMT (CAS, 58.1%; PAD, 43.1%; AAA, 41.1%). There was highest uptake of blood pressure control at 93.0% (lipid-lowering agents, 65.3%; antithrombotics 63.5%). PAD was associated with highest uptake of blood pressure control (PAD 93.9%; CAS, 91.4%; AAA, 91.1%, P =.092) whilst CAS had highest uptake of antithrombotics (CAS 76.3%; PAD, 61.0%; AAA 60.4%, P < .001) and lipid-lowering agents (CAS 78.7%; PAD, 63.1%; AAA, 60.4%, P < .001). Our study indicates suboptimal use of BMT in patients with vascular disease in the community. The risk of CVD in CAS is likely misperceived as higher than PAD and AAA.
DOI
10.1177/00033197231159246
Access Rights
subscription content
Comments
Teh, R., Raymond, W., & Sieunarine, K. (2024). Uptake of best medical therapy: Secondary prevention of cardiovascular disease in vascular surgical patients in Western Australia. Angiology, 75(3), 288-294. https://doi.org/10.1177/00033197231159246